Exploring the medical potential of cone snail venom peptides
“Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery”
['FUNDING_R01'] · UNIVERSITY OF UTAH · NIH-11034052
This study is exploring the helpful substances in cone snail venom to see how they might lead to new treatments for conditions like Alzheimer's disease, with the hope that patients could benefit from these exciting discoveries.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF UTAH (nih funded) |
| Locations | 1 site (SALT LAKE CITY, UNITED STATES) |
| Trial ID | NIH-11034052 on ClinicalTrials.gov |
What this research studies
This research investigates the bioactive components found in the venom of cone snails, which have shown promise in developing new medical treatments. By utilizing advanced techniques like calcium imaging and pharmacology, the researchers aim to discover and characterize these venom components and understand how they interact with biological systems. The study focuses on linking the effects of these components to their molecular targets, which could lead to new insights into treating conditions like Alzheimer's disease. Patients may benefit from potential new therapies derived from these discoveries.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with Alzheimer's disease or related neurodegenerative conditions.
Not a fit: Patients with non-neurological conditions or those not affected by Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel treatments for Alzheimer's disease and other neurological conditions.
How similar studies have performed: Previous research has successfully identified and developed drugs from cone snail venom, indicating a promising avenue for future discoveries.
Where this research is happening
SALT LAKE CITY, UNITED STATES
- UNIVERSITY OF UTAH — SALT LAKE CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: OLIVERA, BALDOMERO M — UNIVERSITY OF UTAH
- Study coordinator: OLIVERA, BALDOMERO M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease